Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
13,375
+17
+0.1% +$1.99K 0.32% 42
2026
Q1
$1.61M Sell
13,358
-2,379
-15% -$275K 0.31% 56
2025
Q4
$1.66M Sell
15,737
-2,237
-12% -$210K 0.32% 45
2025
Q3
$1.51M Buy
17,974
+2,833
+19% +$233K 0.32% 59
2025
Q2
$1.2M Buy
15,141
+854
+6% +$67.9K 0.3% 65
2025
Q1
$1.28M Buy
14,287
+4,256
+42% +$397K 0.35% 60
2024
Q4
$998K Sell
10,031
-714
-7% -$73.6K 0.27% 62
2024
Q3
$1.22M Buy
10,745
+677
+7% +$80.4K 0.35% 51
2024
Q2
$1.25M Sell
10,068
-1,591
-14% -$205K 0.4% 43
2024
Q1
$1.54M Buy
11,659
+590
+5% +$72.7K 0.51% 27
2023
Q4
$1.21M Buy
11,069
+323
+3% +$33.5K 0.53% 25
2023
Q3
$1.11M Buy
10,746
+838
+8% +$90.3K 0.55% 26
2023
Q2
$1.14M Sell
9,908
-9,830
-50% -$1.12M 0.59% 19
2023
Q1
$2.1M Sell
19,738
-6,779
-26% -$732K 1.23% 11
2022
Q4
$2.94M Sell
26,517
-5,044
-16% -$516K 1.9% 9
2022
Q3
$2.72M Buy
31,561
+16,141
+105% +$1.44M 1.91% 14
2022
Q2
$1.43M Buy
15,420
+4,953
+47% +$439K 0.91% 28
2022
Q1
$859K Buy
+10,467
New +$825K 0.48% 60
2021
Q2
$1.57M Buy
20,179
+1,516
+8% +$113K 0.97% 25
2021
Q1
$1.37M Buy
18,663
+2,125
+13% +$157K 1.02% 27
2020
Q4
$1.29M Buy
+16,538
New +$1.26M 1.09% 26

Other funds holding MRK

GoalVest Advisory's MRK Position: Q2 2026 in Review

GoalVest Advisory increased its Merck (MRK) stake by 0.13% in Q2 2026, buying an estimated $1.99K and bringing the position to 13,375 shares worth $1.72M. The position accounts for 0.32% of the portfolio, ranked #42.

GoalVest Advisory first reported a position in MRK in Q4 2020 and has held it in 21 quarters since. The position peaked at $2.94M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GoalVest Advisory held 13,375 shares of Merck worth $1.72M as of Q2 2026.
  • GoalVest Advisory bought 17 Merck shares in Q2 2026, an estimated $1.99K.
  • Merck made up 0.32% of GoalVest Advisory's portfolio in Q2 2026, its #42 holding.
  • GoalVest Advisory first reported a position in Merck in Q4 2020 and has held it in 21 quarters since.
  • GoalVest Advisory's Merck position peaked at $2.94M in Q4 2022.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.